Inside Penn

In brief, what’s happening at Penn—whether it’s across campus or around the world.

Filter Stories

Displaying 2521 - 2525 of 2525
  • Penn Medicine launches new Center for Living Donation to increase transplant opportunities

    The Penn Transplant Institute’s new Center will expand care for living donors, helping to maximize the number of lives saved through liver and kidney transplantation.

    FULL STORY AT Penn Medicine News

  • Penn partners in multi-university research center supporting healthy pregnancies

    A $5 million grant from the National Institutes of Health will help fund research to study how placenta keep harmful substances away from developing babies while still providing proper nutrition. Research will include how transporter proteins carrying nutrients, dietary supplements, medications and toxic chemicals work during pregnancies, how individual placenta cells respond to various stimuli in the laboratory, and how environmental factors influence placental transporters during healthy and unhealthy or complicated pregnancies.

    FULL STORY AT Penn Engineering Today

  • From prints to pixels: ‘Sunset Over Sunset’ explores urbanization in Los Angeles

    The newly-digitized archive of Ed Ruscha's landmark series of Los Angeles photographs examines changes along Sunset Boulevard from 1966 to 2007.

    FULL STORY AT Weitzman School of Design

  • Students’ innovative orthotic device wins Rothberg Catalyzer

    At Penn Health-Tech’s Rothberg Catalyzer  two-day makerthon that challenges interdisciplinary student teams to prototype and pitch medical devices, a team of Mechanical Engineering and Applied Mechanics graduate students won with their orthotic device that children with cerebral palsy can more comfortably wear as they sleep.

    FULL STORY AT Penn Engineering Blog

  • Penn study uncovers possible COVID-19 drugs—including several that are already FDA-approved

    A team led by scientists in the Perelman School has identified nine potential new COVID-19 treatments, including three that are already approved by the Food and Drug Administration (FDA) for treating other diseases. The team screened thousands of existing drugs and drug-like molecules for their ability to inhibit the replication of the COVID-19-causing coronavirus, SARS-CoV-2. 

    FULL STORY AT Penn Medicine News